Amanda Kay, Flagship Senior Partner and Chief Business Development Officer, was joined in the Flagship Studio by Repertoire’s John Delyani, Merck’s Lizabeth Leveille, Generate’s Sahm Nasseri, and Novartis’ Gianfranco de Pascale for a deep dive into early-stage deals between biotech and pharma. Watch the full conversation to hear more about what drives success on both sides of the table, the value of going deep on the science, and the importance of relationship building and trust throughout the process. More from Flagship @ JPM2025 here.
Related Companies
- Repertoire® Immune Medicines Founded: 2019
- Generate:Biomedicines Founded: 2018